Terveystalo revenue and financials

TTALO · Nasdaq Helsinki · EUR

€7.51Change from previous close: +1.35%Absolute change: +€0.10

Close · October 6, 2026

In the fiscal year ended December 2025, Terveystalo reported revenue of €1.28B (−4.56% year over year). Net income was €92.6M, a net margin of 7.2%.

Annual revenue · 2025: €1.28B
  1. €1.26B2022
  2. €1.29B2023
  3. €1.34B2024
  4. €1.28B2025

Fiscal year ending in December. Sources and method on the page Methodology and sources.

At a glance

Revenue growth
−4.56%
2025 vs 2024
Net income growth
+29.15%
2025 vs 2024
Net margin
7.2%
2024: 5.4%

Financial data

Amounts in millions of EUR; per-share values in EUR; shares in millions.

Income statement · Annual
Item20252024202320222021
Total revenue1,2791,3401,2861,259—
Cost of revenue510550536526—
Gross profit769790750733—
Selling, general and administrative13.911.18.78.5—
Operating income14111971.366.0—
EBIT137115-16.240.7—
EBITDA23321790.7144—
Interest expense20.625.722.79.8—
Pre-tax income11689.6-38.930.9—
Income tax23.518.03.36.5—
Net income92.671.7-42.224.4—
Net income to common shareholders92.671.7-42.224.4—
Basic EPS0.730.57-0.330.19—
Diluted EPS0.730.57-0.330.19—
Average shares (basic)127127127127—
Average shares (diluted)127127127127—